🟢 Cingulate is trading 5.9% up in pre-market amid healthcare’s 1.55% pre-market gain

Cingulate is trading at $5.00, up 5.93%, in pre-market, with no identified company-specific catalyst.

• Healthcare is up 1.55% pre-market, providing sector context.
• Schwab reported no headlines for November 4; available after-hours coverage noted no clear company catalyst.
• Major U.S. indices are higher, which may contribute to broader risk-on sentiment, but the evidence does not establish a specific catalyst for Cingulate.